, Volume 14, Issue 4, pp 348–363

NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy

Cell Death and Disease

DOI: 10.1007/s10495-009-0315-0

Cite this article as:
Shen, HM. & Tergaonkar, V. Apoptosis (2009) 14: 348. doi:10.1007/s10495-009-0315-0


It has become increasingly clear that deregulation of the NFκB signaling cascade is a common underlying feature of many human ailments including cancers. The past two decades of intensive research on NFκB has identified the basic mechanisms that govern the functioning of this pathway but uncovering the details of why this pathway works differently in different cellular contexts or how it interacts with other signaling pathways remains a challenge. A thorough understanding of these processes is needed to design better and more efficient therapeutic approaches to treat complex diseases like cancer. In this review, we summarize the literature documenting the involvement of NFκB in cancer, and then focus on the approaches that are being undertaken to develop NFκB inhibitors towards treatment of human cancers.


NFκB p65 Kinase Inhibitors Signaling Cancer IKK 

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of Community, Occupational and Family Medicine, Yong Loo Lin School of Medicine, NUS Graduate School for Integrative Sciences and EngineeringNational University of SingaporeSingaporeRepublic of Singapore
  2. 2.Institute for Molecular and cell BiologySingaporeRepublic of Singapore

Personalised recommendations